JOHN B. SANFILIPPO & SON INC (JBSS) Fundamental Analysis & Valuation

NASDAQ:JBSS • US8004221078

78.35 USD
-0.98 (-1.24%)
Last: Mar 5, 2026, 01:53 PM

This JBSS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

JBSS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 88 industry peers in the Food Products industry. JBSS has an average financial health and profitability rating. JBSS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. JBSS Profitability Analysis

1.1 Basic Checks

  • In the past year JBSS was profitable.
  • JBSS had a positive operating cash flow in the past year.
  • Each year in the past 5 years JBSS has been profitable.
  • JBSS had a positive operating cash flow in each of the past 5 years.
JBSS Yearly Net Income VS EBIT VS OCF VS FCFJBSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.39%, JBSS belongs to the top of the industry, outperforming 96.59% of the companies in the same industry.
  • JBSS has a better Return On Equity (19.01%) than 90.91% of its industry peers.
  • JBSS's Return On Invested Capital of 15.88% is amongst the best of the industry. JBSS outperforms 94.32% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for JBSS is significantly below the industry average of 28.23%.
Industry RankSector Rank
ROA 11.39%
ROE 19.01%
ROIC 15.88%
ROA(3y)12.11%
ROA(5y)13.03%
ROE(3y)18.85%
ROE(5y)20.67%
ROIC(3y)16.04%
ROIC(5y)17.32%
JBSS Yearly ROA, ROE, ROICJBSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • JBSS has a Profit Margin of 6.15%. This is in the better half of the industry: JBSS outperforms 79.55% of its industry peers.
  • In the last couple of years the Profit Margin of JBSS has declined.
  • JBSS has a better Operating Margin (8.86%) than 72.73% of its industry peers.
  • JBSS's Operating Margin has declined in the last couple of years.
  • JBSS has a Gross Margin (19.06%) which is comparable to the rest of the industry.
  • JBSS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.86%
PM (TTM) 6.15%
GM 19.06%
OM growth 3Y-4.93%
OM growth 5Y-3.02%
PM growth 3Y-6.28%
PM growth 5Y-2.84%
GM growth 3Y-4.17%
GM growth 5Y-1.65%
JBSS Yearly Profit, Operating, Gross MarginsJBSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

6

2. JBSS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so JBSS is creating value.
  • Compared to 1 year ago, JBSS has more shares outstanding
  • The number of shares outstanding for JBSS has been increased compared to 5 years ago.
  • JBSS has a worse debt/assets ratio than last year.
JBSS Yearly Shares OutstandingJBSS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
JBSS Yearly Total Debt VS Total AssetsJBSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • JBSS has an Altman-Z score of 5.53. This indicates that JBSS is financially healthy and has little risk of bankruptcy at the moment.
  • JBSS's Altman-Z score of 5.53 is amongst the best of the industry. JBSS outperforms 90.91% of its industry peers.
  • JBSS has a debt to FCF ratio of 1.37. This is a very positive value and a sign of high solvency as it would only need 1.37 years to pay back of all of its debts.
  • JBSS has a better Debt to FCF ratio (1.37) than 87.50% of its industry peers.
  • JBSS has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of JBSS (0.11) is better than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.37
Altman-Z 5.53
ROIC/WACC1.87
WACC8.5%
JBSS Yearly LT Debt VS Equity VS FCFJBSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.27 indicates that JBSS has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.27, JBSS is doing good in the industry, outperforming 65.91% of the companies in the same industry.
  • JBSS has a Quick Ratio of 2.27. This is a bad value and indicates that JBSS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.69, JBSS is doing worse than 64.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 0.69
JBSS Yearly Current Assets VS Current LiabilitesJBSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

3

3. JBSS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.65% over the past year.
  • JBSS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.37% yearly.
  • Looking at the last year, JBSS shows a small growth in Revenue. The Revenue has grown by 2.21% in the last year.
  • JBSS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.70% yearly.
EPS 1Y (TTM)43.65%
EPS 3Y-0.91%
EPS 5Y1.37%
EPS Q2Q%31.9%
Revenue 1Y (TTM)2.21%
Revenue growth 3Y5.02%
Revenue growth 5Y4.7%
Sales Q2Q%4.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y13.01%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.58%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBSS Yearly Revenue VS EstimatesJBSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
JBSS Yearly EPS VS EstimatesJBSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 1 2 3 4 5

5

4. JBSS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 13.08 indicates a correct valuation of JBSS.
  • Based on the Price/Earnings ratio, JBSS is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of JBSS to the average of the S&P500 Index (27.03), we can say JBSS is valued rather cheaply.
  • A Price/Forward Earnings ratio of 13.78 indicates a correct valuation of JBSS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of JBSS indicates a somewhat cheap valuation: JBSS is cheaper than 73.86% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of JBSS to the average of the S&P500 Index (25.11), we can say JBSS is valued slightly cheaper.
Industry RankSector Rank
PE 13.08
Fwd PE 13.78
JBSS Price Earnings VS Forward Price EarningsJBSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 73.86% of the companies in the same industry are more expensive than JBSS, based on the Enterprise Value to EBITDA ratio.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as JBSS.
Industry RankSector Rank
P/FCF 27.95
EV/EBITDA 7.4
JBSS Per share dataJBSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of JBSS may justify a higher PE ratio.
PEG (NY)1.01
PEG (5Y)9.57
EPS Next 2YN/A
EPS Next 3YN/A

3

5. JBSS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.11%, JBSS has a reasonable but not impressive dividend return.
  • JBSS's Dividend Yield is comparable with the industry average which is at 2.23.
  • Compared to the average S&P500 Dividend Yield of 1.82, JBSS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

  • The dividend of JBSS decreases each year by -19.01%.
  • JBSS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-19.01%
Div Incr Years0
Div Non Decr Years0
JBSS Yearly Dividends per shareJBSS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • JBSS pays out 24.86% of its income as dividend. This is a sustainable payout ratio.
DP24.86%
EPS Next 2YN/A
EPS Next 3YN/A
JBSS Yearly Income VS Free CF VS DividendJBSS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M 100M
JBSS Dividend Payout.JBSS Dividend Payout, showing the Payout Ratio.JBSS Dividend Payout.PayoutRetained Earnings

JBSS Fundamentals: All Metrics, Ratios and Statistics

JOHN B. SANFILIPPO & SON INC

NASDAQ:JBSS (3/5/2026, 1:53:10 PM)

78.35

-0.98 (-1.24%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-29
Earnings (Next)04-28
Inst Owners95.31%
Inst Owner Change-1.68%
Ins Owners1.44%
Ins Owner Change4.04%
Market Cap915.91M
Revenue(TTM)1.14B
Net Income(TTM)70.36M
Analysts85.71
Price TargetN/A
Short Float %2.2%
Short Ratio2.82
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend2.1
Dividend Growth(5Y)-19.01%
DP24.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-33.06%
EPS NQ rev (3m)-33.06%
EPS NY rev (1m)-6.12%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.08
Fwd PE 13.78
P/S 0.8
P/FCF 27.95
P/OCF 8.7
P/B 2.47
P/tB 2.58
EV/EBITDA 7.4
EPS(TTM)5.99
EY7.65%
EPS(NY)5.68
Fwd EY7.26%
FCF(TTM)2.8
FCFY3.58%
OCF(TTM)9
OCFY11.49%
SpS97.81
BVpS31.66
TBVpS30.33
PEG (NY)1.01
PEG (5Y)9.57
Graham Number65.32
Profitability
Industry RankSector Rank
ROA 11.39%
ROE 19.01%
ROCE 21.59%
ROIC 15.88%
ROICexc 15.95%
ROICexgc 16.49%
OM 8.86%
PM (TTM) 6.15%
GM 19.06%
FCFM 2.87%
ROA(3y)12.11%
ROA(5y)13.03%
ROE(3y)18.85%
ROE(5y)20.67%
ROIC(3y)16.04%
ROIC(5y)17.32%
ROICexc(3y)16.09%
ROICexc(5y)17.36%
ROICexgc(3y)16.85%
ROICexgc(5y)18.29%
ROCE(3y)22.35%
ROCE(5y)24.36%
ROICexgc growth 3Y-10.55%
ROICexgc growth 5Y-7.62%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y-6.93%
OM growth 3Y-4.93%
OM growth 5Y-3.02%
PM growth 3Y-6.28%
PM growth 5Y-2.84%
GM growth 3Y-4.17%
GM growth 5Y-1.65%
F-Score6
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.37
Debt/EBITDA 0.32
Cap/Depr 259.31%
Cap/Sales 6.34%
Interest Coverage 250
Cash Conversion 81.41%
Profit Quality 46.57%
Current Ratio 2.27
Quick Ratio 0.69
Altman-Z 5.53
F-Score6
WACC8.5%
ROIC/WACC1.87
Cap/Depr(3y)134.82%
Cap/Depr(5y)127.89%
Cap/Sales(3y)3.1%
Cap/Sales(5y)2.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.65%
EPS 3Y-0.91%
EPS 5Y1.37%
EPS Q2Q%31.9%
EPS Next Y13.01%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.21%
Revenue growth 3Y5.02%
Revenue growth 5Y4.7%
Sales Q2Q%4.55%
Revenue Next Year5.58%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.04%
EBIT growth 3Y-0.15%
EBIT growth 5Y1.53%
EBIT Next Year50.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.37%
OCF growth 3Y15.94%
OCF growth 5Y-13.64%

JOHN B. SANFILIPPO & SON INC / JBSS FAQ

What is the ChartMill fundamental rating of JOHN B. SANFILIPPO & SON INC (JBSS) stock?

ChartMill assigns a fundamental rating of 5 / 10 to JBSS.


Can you provide the valuation status for JOHN B. SANFILIPPO & SON INC?

ChartMill assigns a valuation rating of 5 / 10 to JOHN B. SANFILIPPO & SON INC (JBSS). This can be considered as Fairly Valued.


What is the profitability of JBSS stock?

JOHN B. SANFILIPPO & SON INC (JBSS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for JBSS stock?

The Price/Earnings (PE) ratio for JOHN B. SANFILIPPO & SON INC (JBSS) is 13.08 and the Price/Book (PB) ratio is 2.47.


What is the financial health of JOHN B. SANFILIPPO & SON INC (JBSS) stock?

The financial health rating of JOHN B. SANFILIPPO & SON INC (JBSS) is 6 / 10.